January 6, 2012 – A study led by researchers from the University of North Carolina at Chapel Hill School of Medicine has identified a molecular pathway that leads to this abnormal blood clotting and have turned it off using a popular class of cholesterol-lowering drugs; statins.

January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac perfusion radiotracer with a list of actions to bring the product back to market.

January 5, 2012 – Ambucor Health Solutions (AHS) has said it is expanding its cardiovascular implantable electronic devices (CIED) monitoring program for pacemaker and implantable cardioverter defibrillator (ICD) monitoring services.

January 5, 2012 – During RSNA 2011, TeraRecon Inc. demonstrated a suite of innovative tools for its iNtuition solution to support new applications for volumetric acquisition modalities, such as computed tomography (CT), magnetic resonance (MR) and positron emission tomography (PET).

January 5, 2011 – Bayer HealthCare's oral anticoagulant tablet Xarelto (rivaroxaban) has been approved for use in the United Kingdom in two important blood-clotting disorders

January 4, 2012 - A study reported in the current issue of Pediatric and Developmental Pathology compares cardiac tissue from 12 patients with histiocytoid cardiomyopathy (HC) and 12 age-matched controls. Researchers found differences in gene expression that could indicate a predisposition for HC.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now